AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
A 6 Months NIS to Evaluate the Use of Rescue Medication and Quality of Life in Adult Asthmatic Subjects Treated With Symbicort® SMART®
Completed
- Conditions
- Asthma
- First Posted Date
- 2009-04-21
- Last Posted Date
- 2011-03-31
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 500
- Registration Number
- NCT00884689
- Locations
- 🇩🇪
Research Site, Weyhe, Germany
Structured Treatment of Gastroesophageal Reflux in a Company Health Care Setting, -Effect on Quality of Life, Symptoms and Productivity
Completed
- Conditions
- GERD
- First Posted Date
- 2009-04-20
- Last Posted Date
- 2010-12-07
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 36
- Registration Number
- NCT00884247
- Locations
- 🇸🇪
Research Site, Hälsocenter, Södertälje, Sweden
Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer
Completed
- Conditions
- Post MenopausalBreast Cancer
- First Posted Date
- 2009-04-20
- Last Posted Date
- 2010-04-20
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 515
- Registration Number
- NCT00884143
- Locations
- 🇮🇹
Research Site, Verona, Italy
Efficacy and Safety of Quetiapine Versus Quetiapine Plus Lithium in Bipolar Depression
Phase 3
Completed
- Conditions
- Acute Bipolar Depression
- Interventions
- First Posted Date
- 2009-04-17
- Last Posted Date
- 2012-07-11
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 421
- Registration Number
- NCT00883493
- Locations
- 🇻🇪
Research Site, Caracas, Venezuela
Efficacy and Safety of Quetiapine Fumarate in the Treatment of Schizophrenic Patients
Phase 3
Completed
- Conditions
- Schizophrenia
- Interventions
- First Posted Date
- 2009-04-16
- Last Posted Date
- 2012-05-15
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 388
- Registration Number
- NCT00882518
- Locations
- 🇨🇳
Research Site, Shanghai, China
Evaluation of the Control Level of Asthmatic Patients With Seasonal Increase of Respiratory Symptoms (High and/or Low)
Completed
- Conditions
- AsthmaRespiratory Symptoms
- First Posted Date
- 2009-04-16
- Last Posted Date
- 2009-11-17
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 3300
- Registration Number
- NCT00882128
- Locations
- 🇫🇷
Research Site, Zuydcoote, France
European Study of Cardiovascular Risk
Completed
- Conditions
- Cardiovascular Risk FactorsHyperlipidemiaHypertensionDiabetesObesitySmoking
- First Posted Date
- 2009-04-16
- Last Posted Date
- 2009-10-29
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 7200
- Registration Number
- NCT00882336
- Locations
- 🇬🇧
Research Site, Worthing, United Kingdom
Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer (BC)
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2009-04-14
- Last Posted Date
- 2011-11-30
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 57
- Registration Number
- NCT00880711
- Locations
- 🇦🇹
Research Site, Wr. Neustadt, Austria
A Study of the Effect of Patient Education (Talking Health Together) in Improving Doctor-patient Communication
Not Applicable
Completed
- Conditions
- Doctor-patient Communication Improvement
- Interventions
- Behavioral: THT PACE TrainingOther: placebo
- First Posted Date
- 2009-04-10
- Last Posted Date
- 2011-08-22
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 322
- Registration Number
- NCT00879736
- Locations
- 🇨🇦
Research Site, Oakville, Ontario, Canada
A Study to Determine the Effect of Food on the Pharmacokinetics of Oral AZD8931 Tablets
- First Posted Date
- 2009-04-10
- Last Posted Date
- 2009-10-23
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 24
- Registration Number
- NCT00879346
- Locations
- 🇬🇧
Research Site, Alderley Park, Cheshire, United Kingdom